Clinical Outcomes of Cataract Surgery in Patients with Sjögren's Syndrome.
Donghyeon LeeCharm KimKyeongjoo LeeJin Kwon ChungPublished in: Diagnostics (Basel, Switzerland) (2022)
This study compared the biometric accuracy and refractive outcomes, and ocular surface changes after cataract surgery in patients with Sjögren’s syndrome (SS, S group), non-SS dry eye patients (D group), and healthy controls (C group). The medical records of patients who underwent cataract surgery and met certain inclusion criteria were reviewed. In total, 167 eyes of 87 patients were enrolled. Refractive parameters were analyzed via optical biometry and combined ultrasound biometry and automated refractokeratometry. The mean absolute errors (MAEs), the uncorrected distance visual acuities (UDVAs), changes in the ocular staining score (OSS), and anterior chamber cell grades were compared for 12 months postoperatively. The S group evidenced more severe and persistent OSS exacerbation after cataract surgery; the OSS returned to baseline by 3 months postoperatively. The mean keratometric values showed a significant linear correlation. There was no significant intergroup difference in either the MAEs (p > 0.530) or anterior chamber inflammation (p > 0.436). The postoperative UDVA of the S group was poorer than that of the C group from 3 months postoperatively (p < 0.047) but not different from that of the D group (p > 0.311). With preoperative ocular surface optimization and optimal postoperative treatment of superficial keratitis, the refractive outcomes of SS patients were comparable to those of other groups and the postoperative UDVA was not inferior to that of non-SS dry eye patients.
Keyphrases
- end stage renal disease
- cataract surgery
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- patients undergoing
- prognostic factors
- rheumatoid arthritis
- emergency department
- stem cells
- magnetic resonance imaging
- high resolution
- oxidative stress
- single cell
- systemic lupus erythematosus
- insulin resistance
- cell therapy
- electronic health record
- drug induced